Opdenakker G - Search Results

1

Limitations of neutrophil depletion by anti-Ly6G antibodies in two heterogenic immunological models.

Pollenus E, Malengier-Devlies B, Vandermosten L, Pham TT, Mitera T, Possemiers H, Boon L, Opdenakker G, Matthys P, Van den Steen PE. Pollenus E, et al. Among authors: opdenakker g. Immunol Lett. 2019 Aug;212:30-36. doi: 10.1016/j.imlet.2019.06.006. Epub 2019 Jun 18. Immunol Lett. 2019. PMID: 31226358

2

Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia.

Matthys P, Heremans H, Opdenakker G, Billiau A. Matthys P, et al. Among authors: opdenakker g. Eur J Cancer. 1991;27(2):182-7. doi: 10.1016/0277-5379(91)90483-t. Eur J Cancer. 1991. PMID: 1827286

3

Cloning, bacterial expression and biological characterization of recombinant human granulocyte chemotactic protein-2 and differential expression of granulocyte chemotactic protein-2 and epithelial cell-derived neutrophil activating peptide-78 mRNAs.

Froyen G, Proost P, Ronsse I, Mitera T, Haelens A, Wuyts A, Opdenakker G, Van Damme J, Billiau A. Froyen G, et al. Among authors: opdenakker g. Eur J Biochem. 1997 Feb 1;243(3):762-9. doi: 10.1111/j.1432-1033.1997.00762.x. Eur J Biochem. 1997. PMID: 9057843 Free article.

4

Cytokine and protease glycosylation as a regulatory mechanism in inflammation and autoimmunity.

Van den Steen P, Rudd PM, Dwek RA, Van Damme J, Opdenakker G. Van den Steen P, et al. Among authors: opdenakker g. Adv Exp Med Biol. 1998;435:133-43. doi: 10.1007/978-1-4615-5383-0_13. Adv Exp Med Biol. 1998. PMID: 9498072 Review.

5

Concepts and principles of O-linked glycosylation.

Van den Steen P, Rudd PM, Dwek RA, Opdenakker G. Van den Steen P, et al. Among authors: opdenakker g. Crit Rev Biochem Mol Biol. 1998;33(3):151-208. doi: 10.1080/10409239891204198. Crit Rev Biochem Mol Biol. 1998. PMID: 9673446 Review.

6

Oligosaccharides of recombinant mouse gelatinase B variants.

Van den Steen P, Rudd PM, Proost P, Martens E, Paemen L, Küster B, van Damme J, Dwek RA, Opdenakker G. Van den Steen P, et al. Among authors: opdenakker g. Biochim Biophys Acta. 1998 Nov 27;1425(3):587-98. doi: 10.1016/s0304-4165(98)00113-5. Biochim Biophys Acta. 1998. PMID: 9838222

7

Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.

Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Van den Steen PE, et al. Among authors: opdenakker g. Blood. 2000 Oct 15;96(8):2673-81. Blood. 2000. PMID: 11023497 Free article.

8

Gelatinase B functions as regulator and effector in leukocyte biology.

Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J. Opdenakker G, et al. J Leukoc Biol. 2001 Jun;69(6):851-9. J Leukoc Biol. 2001. PMID: 11404367 Review.

9

Gelatinase B: a tuner and amplifier of immune functions.

Opdenakker G, Van den Steen PE, Van Damme J. Opdenakker G, et al. Trends Immunol. 2001 Oct;22(10):571-9. doi: 10.1016/s1471-4906(01)02023-3. Trends Immunol. 2001. PMID: 11574282 Review.

10

Matrix remodelling enzymes, the protease cascade and glycosylation.

Van den Steen PE, Opdenakker G, Wormald MR, Dwek RA, Rudd PM. Van den Steen PE, et al. Among authors: opdenakker g. Biochim Biophys Acta. 2001 Oct 3;1528(2-3):61-73. doi: 10.1016/s0304-4165(01)00190-8. Biochim Biophys Acta. 2001. PMID: 11687291 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters